Akorn-Strides, LLC Announces FDA Approval For Flumazenil Injection USP, 0.1 Mg/mL - 5mL And 10 ML Multiple Dose Vials
Akorn-Strides, LLC announced the approval of an ANDA for Flumazenil Injection USP, 0.1 mg/mL, packaged in 5 mL and 10 mL Multiple Dose Vials. Akorn-Strides, LLC is a Joint Venture that was formed in 2005 by Akorn, Inc. (NASDAQ:AKRX) and Strides Arcolab Limited (NSE:STAR) (BSE:532531).
More: continued here
Filed under: Pharma Industry on May 22nd, 2008